Molecular signaling network complexity is correlated with cancer patient survivability

Proceedings of the National Academy of Sciences of the United States of America

Volumn 109, Issue 23, 2012, Pages 9209-9212

  Breitkreutz, Dylan ^a   Hlatky, Lynn ^b   Rietman, Edward ^b   Tuszynski, Jack A ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Basal cell carcinoma; Degree distribution; Network entropy; Prostate cancer; Signaling pathway

Indexed keywords

ARTICLE; CANCER PATIENT; CANCER SURVIVAL; HUMAN; MOLECULAR INTERACTION; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION;

COMPUTATIONAL BIOLOGY; DRUG DISCOVERY; ENTROPY; HUMANS; JAPAN; METABOLIC NETWORKS AND PATHWAYS; NEOPLASMS; SIGNAL TRANSDUCTION; SURVIVAL RATE;

EID: 84861863981     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1201416109     Document Type: Article

References (38)

1. MacDonald P (2012) Chemotherapeutic Drugs. Emergencies in Pediatric Oncology, eds Scheinemann K, Boyce AE (Springer, New York), pp 105-120.
2. Kandalaft LE, Motz GT, Busch J, Coukos G (2011) Angiogenesis and the tumor vasculature as antitumor immune modulators: The role of vascular endothelial growth factor and endothelin. Curr Top Microbiol Immunol 344:129-148.
3. Marshall E (2011) Cancer research and the $90 billion metaphor. Science 331: 1540-1541.
4. Brenner H (2002) Long-term survival rates of cancer patients achieved by the end of the 20th century: A period analysis. Lancet 360:1131-1135.
5. Ellison LF, Gibbons L (2006) Survival from cancer - Up-to-date predictions using period analysis. Health Rep 17:19-30.
6. Jemal A, et al. (2009) Cancer statistics, 2009. CA Cancer J Clin 59:225-249.
7. Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100:57-70. (Pubitemid 30046295)
8. Sonnenschein C, Soto AM (2008) Theories of carcinogenesis: An emerging perspective. Semin Cancer Biol 18:372-377.
9. Edelman EJ, Guinney J, Chi JT, Febbo PG, Mukherjee S (2008) Modeling cancer progression via pathway dependencies. PLOS Comput Biol 4:e28.
10. Nacher JC, Schwartz JM (2008) A global view of drug-therapy interactions. BMC Pharmacol 8:5.
11. Yildirim MA, Goh KI, Cusick ME, Barabási AL, VidalM(2007) Drug-target network. Nat Biotechnol 25:1119-1126. (Pubitemid 47538114)
12. Dreze M, et al. (2010) High-quality binary interactome mapping. Methods Enzymol 470:281-315.
13. Moelling K, Schad K, Bosse M, Zimmermann S, Schweneker M (2002) Regulation of Raf-Akt Cross-talk. J Biol Chem 277:31099-31106. (Pubitemid 34970815)
14. Newman MEJ (2010) Networks: An Introduction (Oxford Univ Press, Oxford, UK).
15. Newman MEJ, Barabási AL, Watts DJ (2006) The Structure and Dynamics of Networks (Princeton Univ Press, Princeton, NJ).
16. Mason O, Verwoerd M (2007) Graph theory and networks in biology. IET Syst Biol 1: 89-119. (Pubitemid 46488242)
17. Keller EF (2005) Revisiting "scale-free" networks. Bioessays 27:1060-1068.
18. Stokić D, Hanel R, Thurner S (2008) Inflation of the edge of chaos in a simple model of gene interaction networks. Phys Rev E Stat Nonlin Soft Matter Phys 77:061917.
19. Jeong H, Tombor B, Albert R, Oltvai ZN, Barabási AL (2000) The large-scale organization of metabolic networks. Nature 407:651-654.
20. Albert R, Jeong H, Barabási AL (2000) Error and attack tolerance of complex networks. Nature 406:378-382. (Pubitemid 30625551)
21. Kanehisa M, Goto S (2000) KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res 28:27-30. (Pubitemid 30047706)
22. Kanehisa M, Goto S, Kawashima S, Okuno Y, Hattori M (2004) The KEGG resource for deciphering the genome. Nucleic Acids Res 32(Database issue):D277-D280. (Pubitemid 38081656)
23. Kanehisa M, et al. (2006) From genomics to chemical genomics: New developments in KEGG. Nucleic Acids Res 34(Database issue):D354-D357.
24. Kanehisa M, Goto S, Furumichi M, Tanabe M, Hirakawa M (2010) KEGG for representation and analysis of molecular networks involving diseases and drugs. Nucleic Acids Res 38(Database issue):D355-D360.
25. Schaefer CF (2004) Pathway databases. Ann N Y Acad Sci 1020:77-91.
26. Daya-Grosjean L, Couvé-Privat S (2005) Sonic hedgehog signaling in basal cell carcinomas. Cancer Lett 225:181-192. (Pubitemid 40835865)
27. Saldanha G, Ghura V, Potter L, Fletcher A (2004) Nuclear beta-catenin in basal cell carcinoma correlates with increased proliferation. Br J Dermatol 151:157-164. (Pubitemid 39061293)
28. Herzberg AJ, et al. (1993) DNA ploidy of basal cell carcinoma determined by image cytometry of fresh smears. J Cutan Pathol 20:216-222. (Pubitemid 23210539)
29. Dhillon AS, Hagan S, Rath O, Kolch W (2007) MAP kinase signalling pathways in cancer. Oncogene 26:3279-3290. (Pubitemid 46763021)
30. Zhang JD, Wiemann S (2009) KEGGgraph: A graph approach to KEGG PATHWAY in R and bioconductor. Bioinformatics 25:1470-1471.
31. De Las Rivas J, Fontanillo C (2010) Protein-protein interactions essentials: Key concepts to building and analyzing interactome networks. PLOS Comput Biol 6:e1000807.
32. Albert R, Barabási AL (2002) Statistical mechanics of complex networks. Rev Mod Phys 74:47-97.
33. Dorogovtsev SN, Mendes JFF (2004) Evolution of Networks: From Biological Nets to the Internet and WWW (Oxford Univ Press, Oxford, UK).
34. Junker BH, Schreiber F (2008) Analysis of Biological Networks (Wiley Interscience, New York).
35. Wang B, Tang H, Guo C, Xiu Z (2006) Entropy optimization of scale-free networks'robustness to random failures. Physica A 363:591-596. (Pubitemid 43375040)
36. Hornberg JJ, Bruggeman FJ, Westerhoff HV, Lankelma J (2006) Cancer: A systems biology disease. Biosystems 83:81-90. (Pubitemid 43199809)
37. Ghali L, Wong ST, Green J, Tidman N, Quinn AG (1999) Gli1 protein is expressed in basal cell carcinomas, outer root sheath keratinocytes and a subpopulation of mesenchymal cells in normal human skin. J Invest Dermatol 113:595-599. (Pubitemid 29489622)
38. Yu H, et al. (2008) High-quality binary protein interaction map of the yeast interactome network. Science 322:104-110.